Highlights from the San Antonio Breast Cancer Symposium

OBTNMarch 2008
Volume 2
Issue 3

In this issue, Oncology & Biotechnology News' editors focus on the 30th Annual San Antonio Breast Cancer Symposium (SABCS), held in December.

Reporting on new research and emerging trends

In this month’s issue of Oncology & Biotech News, our editors focus on the 30th Annual San Antonio Breast Cancer Symposium (SABCS), held in December. More than 8,000 clinicians and other breast cancer specialists from around the world attended this year’s conference. The SABCS remains a unique setting for providing cutting edge data on all aspects of breast cancer and premalignant breast disease. Physicians and researchers, as well as other health care professionals, focused on breast cancer research as well as its management and treatment.

Physicians’ Financial News

In Oncology & Biotech News, our departments provide various perspectives for the oncology professional. For example, in this month’s , besides providing news from the biotech and pharmaceutical industry, we also profile Novartis and its robust oncology pipeline. As you can see from the article on page 30, Novartis’ pipeline is significant and points to an interesting direction in cancer care. Moreover, the large number of compounds—from various companies— that target a wide variety of cancer types and are in Phase I and II trials will offer oncology professionals numerous cutting-edge products and therapies.

Global Reports

Clinical Trial Reports

The Academy

Reimbursement and Managed Care News

Our other monthly columns—, , , and —which appear in this issue are meant to provide the practicing oncologist with the perspective needed to keep abreast of the industry. As with our meeting highlights and news items, these departments provide reports specifically for the community-based oncologist.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.